Literature DB >> 18475537

Heparan sulphate inhibition of cell proliferation induced by TGFbeta and PDGF.

L E Silber1, J M Walenga, J Fareed, E J Kovacs.   

Abstract

The effect of glycosaminoglycans (GAGs) on the proliferation of smooth muscle cells (SMC) and fibroblasts was assessed by culturing cells with or without GAGs. Porcine heparan sulphate (HS) inhibited proliferation in a dose dependent manner. At 167 mug/ml of HS this reached 88% and 72% inhibition of SMC and fibroblast growth, respectively. Pig and beef mucosal heparins also blocked proliferation, but to a lesser extent. In contrast, beef lung heparin, chondroitin sulphate, and dermatan sulphate failed to block growth factor induced proliferation. Continuous presence of HS was not required, suggesting that the inhibitory effects resulted from a direct effect on the cell rather than an interaction of the GAG with growth factors. The mechanism by which GAGs inhibit proliferation will be addressed in future studies.

Entities:  

Year:  1993        PMID: 18475537      PMCID: PMC2365412          DOI: 10.1155/S0962935193000419

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  17 in total

Review 1.  Regulation of vascular smooth muscle cell growth by heparin and heparan sulfates.

Authors:  J J Castellot; T C Wright; M J Karnovsky
Journal:  Semin Thromb Hemost       Date:  1987-10       Impact factor: 4.180

2.  Structural determinants of heparin's growth inhibitory activity. Interdependence of oligosaccharide size and charge.

Authors:  T C Wright; J J Castellot; M Petitou; J C Lormeau; J Choay; M J Karnovsky
Journal:  J Biol Chem       Date:  1989-01-25       Impact factor: 5.157

3.  Suppression of TNF-stimulated proliferation of diploid fibroblasts and TNF-induced cytotoxicity against transformed fibroblasts by TGF-beta.

Authors:  R Kamijo; K Takeda; M Nagumo; K Konno
Journal:  Biochem Biophys Res Commun       Date:  1989-01-16       Impact factor: 3.575

4.  Biosynthesis of heparin. Relationship between the polymerization and sulphation processes.

Authors:  K Lidholt; L Kjellén; U Lindahl
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

5.  Heparins: varying effects on cell proliferation in vitro and lack of correlation with anticoagulant activity.

Authors:  M M Lippman; M B Mathews
Journal:  Fed Proc       Date:  1977-01

6.  Endothelial heparan sulfate proteoglycan. I. Inhibitory effects on smooth muscle cell proliferation.

Authors:  W E Benitz; R T Kelley; C M Anderson; D E Lorant; M Bernfield
Journal:  Am J Respir Cell Mol Biol       Date:  1990-01       Impact factor: 6.914

7.  Heparin suppresses the induction of c-fos and c-myc mRNA in murine fibroblasts by selective inhibition of a protein kinase C-dependent pathway.

Authors:  T C Wright; L A Pukac; J J Castellot; M J Karnovsky; R A Levine; H Y Kim-Park; J Campisi
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

8.  Antiproliferative effects of heparin on vascular smooth muscle cells are reversed by epidermal growth factor.

Authors:  C F Reilly; L M Fritze; R D Rosenberg
Journal:  J Cell Physiol       Date:  1987-05       Impact factor: 6.384

9.  Human arterial smooth muscle cells in culture. Effects of platelet-derived growth factor and heparin on growth in vitro.

Authors:  G Fager; G K Hansson; P Ottosson; B Dahllöf; G Bondjers
Journal:  Exp Cell Res       Date:  1988-06       Impact factor: 3.905

10.  Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle.

Authors:  C F Reilly; M S Kindy; K E Brown; R D Rosenberg; G E Sonenshein
Journal:  J Biol Chem       Date:  1989-04-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.